• Be A Partner
  • Social Responsibility
    • Students Training
  • IR
    • Investor Relations
    • Financial Charts
    • Annual Reports
  • News
    • PRESS RELEASES
    • SOCIAL EVENTS
    • CONFERENCES
  • Careers
  • Covid-19
  • Report a side effect
  • Contact Us
    • Branches
  • Home
  • We are Eipico
    We are Eipico
    EIPICO was established in Tenth of Ramadan City in 1980, with a capital of EGP 7 Million.
    • Uniqueness
      • WHO Approval
      • Sterile products Area
      • Automatic Ampoules Inspection
      • Eipico Ophthalmology
      • Primary packaging materials
      • Restricted-access barrier system
      • Distribution Channel
    • Our History
    • Vision, Mission & Values
    • Chairman Message
    • Eipico Employees
    • Manufacturing Facilities
    • Media Library
  • Global
    Global
    EIPICO is ranked Number 1 in Egyptian Exports of Pharmaceutical Products, capturing 29% of Egypt’s Total Exports of Pharmaceutical Products, by Value.
    • Eipico Destination
  • Manufacturing Facilities
    Manufacturing Facilities
    EIPICO is the Leading Egyptian Pharmaceutical Company, in Production, by Units. It is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Factory 1
    • Factory 2
    • Factory 3 (Biotechnology)
    • Eiaco Factory
    • Batterjee Factory
    • EIPICO Plastic Factory
  • R&D And Quality
    R&D And Quality
    EIPICO provides High Quality Pharmaceutical Products at reasonable prices, thus assisting human healthcare improvement .
    • Quality Assurance
    • Quality Control
    • R&D
    • Regulatory Affairs
    • Global Accreditation
    • Track and Trace
  • Products
    Products
    EIPICO produces 400 Pharmaceutical Products covering 25 therapeutic classes and it is the Major Provider of Antibiotics, Lyophilized products and Spansule Capsules, to the Egyptian market.
    • Eipico Products
      • By Alphabet
  • Biotechnology
Product Prescribing Information
You are here : > Products >> Eipico Products >Product Prescribing Information
CONTA-FLU


Display

  • Prescription Information
  • Composition


    Each tablet contains: 
    Pseudoephedrine hydrochloride ................................................... 30 mg
    Chlorpheniramine maleate .............................................................. 3 mg
    Propyphenazone ........................................................................... 200 mg 

                                                        

    Therapeutic Indications           

                 

    Symptomatic relief of common cold, upper respiratory tract congestion, allergic rhinitis, sinusitis, and Eustachian tube congestion.

                                                          

    Dosage and Administration      

                        

    Adult dose: 1 tablet 3 times/day or as directed by the physician. 

                                                              

    Contraindications          

              

    Known hypersensitivity to any component. Patients with severe hypertension or severe coronary artery disease.

                                                            

    Warnings and Precautions       

                       

    CONTA-FLU should be used with caution in: 
    Patients with hypertension, cardiac disease, diabetes, glaucoma, urinary retention, hyperthyroidism, and prostatic hyperplasia.
    Pregnancy and lactation.

                                                               

    Drug Interactions      

                       

    CONTA-FLU may enhance the sedative effects of CNS depressants such as hypnotics and sedatives.
    Sympathomimetics interact with monoamine oxidase inhibitors and should not be given to patients receiving such treatment or within 14 days of its termination.

                                                                   

    Effects on ability to drive and to use machines              

             

    As with other sedating antihistamines, patients who drive or operate machinery should be warned of the possibility of drowsiness.

                                                             

    Undesirable Effects          

                    

    Drowsiness, nervousness, and dry mouth may occur.                                                     


    Pharmacological Properties             

                  

    CONTA-FLU is an effective formulation which ensures a prompt relief of symptoms due to common cold, flu, or other upper respiratory allergies.
    Pseudoephedrine has a similar action to ephedrine but with negligible stimulating effects on CNS.
    Chlorpheniramine maleate is a potent antihistamine and is used for the symptomatic relief of allergic conditions.
    Propyphenazone has effective analgesic and antipyretic properties.
    Pharmacokinetics:
    CONTA-FLU components are absorbed from the gastrointestinal tract following oral administration. Pseudoephedrine and chlorpheniramine are metabolized in the liver. Unchanged components and metabolites are excreted primarily in the urine.

                                                                

    Storage      

                      

    Store at a temperature not exceeding 30°C.

                                                                  

    Packaging              

           

    CONTA-FLU Tablets:  Box containing 2 blisters of 10 tablets each. 




WE ARE EIPICO

  • Uniqueness
  • Our History
  • Vision, Mission & Values
  • Chairman Message
  • Eipico Employees

Manufacturing Facilities

  • Factory 1
  • Factory 2
  • Factory 3
  • Eiaco Factory
  • Batterjee Factory
  • Plastic Factory

Products

  • Eipico Product
  • Eipico Products By Alphabet

Contact Us

EIPICO, Tenth of Ramadan City - 1st Industrial Zone B1, Egypt.

Telephone : +20554499199
Fax : +20554499306

eipico@eipico.com.eg

Back to top
Powered by EIPICO Team
    Visitors Count : 767302